147 related articles for article (PubMed ID: 12805074)
1. Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.
Jarvik GP; Hatsukami TS; Carlson C; Richter RJ; Jampsa R; Brophy VH; Margolin S; Rieder M; Nickerson D; Schellenberg GD; Heagerty PJ; Furlong CE
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1465-71. PubMed ID: 12805074
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
3. Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia.
Roest M; Jansen AC; Barendrecht A; Leus FR; Kastelein JJ; Voorbij HA
Clin Biochem; 2005 Feb; 38(2):123-7. PubMed ID: 15642273
[TBL] [Abstract][Full Text] [Related]
4. Haplotype-phenotype relationships of paraoxonase-1.
Chen J; Chan W; Wallenstein S; Berkowitz G; Wetmur JG
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):731-4. PubMed ID: 15767359
[TBL] [Abstract][Full Text] [Related]
5. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
9. PON1 activity and genotype in patients with arterial ischemic stroke and in healthy individuals.
Schiavon R; Turazzini M; De Fanti E; Battaglia P; Targa L; Del Colle R; Fasolin A; Silvestri M; Biasioli S; Guidi G
Acta Neurol Scand; 2007 Jul; 116(1):26-30. PubMed ID: 17587252
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms and activity of PON1 in a Mexican population.
Rojas-García AE; Solís-Heredia MJ; Piña-Guzmán B; Vega L; López-Carrillo L; Quintanilla-Vega B
Toxicol Appl Pharmacol; 2005 Jun; 205(3):282-9. PubMed ID: 15922013
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries.
Najafi M; Gohari LH; Firoozrai M
Thromb Res; 2009; 123(3):503-10. PubMed ID: 18433845
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?
Mackness M; Mackness B
Free Radic Biol Med; 2004 Nov; 37(9):1317-23. PubMed ID: 15454272
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients.
Parra S; Marsillach J; Aragonés G; Beltrán R; Montero M; Coll B; Mackness B; Mackness M; Alonso-Villaverde C; Joven J; Camps J
J Infect Dis; 2010 Feb; 201(4):627-34. PubMed ID: 20078196
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor.
Deakin S; Leviev I; Brulhart-Meynet MC; James RW
Biochem J; 2003 Jun; 372(Pt 2):643-9. PubMed ID: 12639220
[TBL] [Abstract][Full Text] [Related]
16. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.
Morahan JM; Yu B; Trent RJ; Pamphlett R
Neurotoxicology; 2007 May; 28(3):532-40. PubMed ID: 17204329
[TBL] [Abstract][Full Text] [Related]
17. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
[TBL] [Abstract][Full Text] [Related]
18. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
Tripi LM; Manzi S; Chen Q; Kenney M; Shaw P; Kao A; Bontempo F; Kammerer C; Kamboh MI
Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
[TBL] [Abstract][Full Text] [Related]
19. Association between PON1 5'-regulatory region polymorphisms, PON1 activity and ischemic stroke.
Kim NS; Kang BK; Cha MH; Oh SM; Ko MM; Bang OS
Clin Biochem; 2009 Jun; 42(9):857-63. PubMed ID: 19233151
[TBL] [Abstract][Full Text] [Related]
20. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
